BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28

• Drug Development

  BioMarin Pharmaceutical Inc. Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA

  February 1, 2011

   · 

  5 min read
• Business

  CardioGenics Holdings Inc. to Continue Commercialization of its Magnetic Beads with Merck Chimie SAS

  February 1, 2011

   · 

  3 min read
• Pharm Country

  Savient Pharmaceuticals, Inc. Prices $200 Million In Convertible Senior Notes

  February 1, 2011

   · 

  3 min read
• Policy

  Omeros Corporation Announces Eligibility of OMS103HP for European Medicines Evaluation Agency Centralized Marketing Application

  February 1, 2011

   · 

  3 min read
• Pharm Country

  Nephros Inc. Rights Offering Registration Statement Declared Effective

  February 1, 2011

   · 

  6 min read
• Pharm Country

  Quest Diagnostics Inc. Agrees to Repurchase 15.4 Million Shares From Largest Shareholder

  February 1, 2011

   · 

  2 min read
• Business

  Pervasis Therapeutics in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says

  February 1, 2011

   · 

  1 min read
• Lone Star Bio

  Erchonia Medical Laser May Help Cancer Patients With Radiation Treatments

  February 1, 2011

   · 

  2 min read
• Business

  Scripps President Richard Lerner To Step Down, Be Replaced by Berkeley Chemist, Sources Say

  February 1, 2011

   · 

  1 min read
• Lone Star Bio

  Emerging Healthcare Solutions, Inc.: Stem Cell Breakthrough May Bring Much in Store for NASA Bioreactor

  February 1, 2011

   · 

  1 min read